Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Mistakes at UK COVID testing lab may have led to deaths of 20 people

Published 29/11/2022, 14:53
© Reuters. FILE PHOTO: People wearing protective face masks walk through Waterloo train station, amid the coronavirus disease (COVID-19) outbreak, in London, Britain, January 3, 2022. REUTERS/Henry Nicholls

By Andrew MacAskill

LONDON (Reuters) -England's government agency responsible for responding to public health emergencies said mistakes at a testing laboratory led to misreporting of tens of thousands of positive COVID-19 cases as negative and may have resulted in the deaths of about 20 people.

Britain has one of the highest coronavirus death tolls in the world, with more than 177,000 deaths since the pandemic started in 2020.

Many experts have said the contact tracing programme fell well short of the "world-beating" system the government had promised.

An investigation by the UK's Health Security Agency (UKHSA) found the Immensa laboratory in central England was found to have misreported around 39,000 tests as negative when they should have been positive between Sept. 2 and Oct. 12 last year.

The cause of the mistakes was the incorrect setting of the threshold levels for reporting positive and negative results of PCR samples for COVID-19, UKHSA said in a report after completing an investigation.

As a result, many people would have continued with their daily lives and not self-isolated even though they had COVID.

The UKHSA said the mistakes could have led to as many as 55,000 additional infections in areas where the false negatives were reported.

Immensa Health Clinic, the private company who run the lab, was founded in May 2020, and has been awarded contracts worth 170 million pounds ($203.63 million) to process results of PCR tests.

Dante Labs, the owners of Immensa, did not immediately respond to a request for comment.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Through this investigation we have looked carefully at the arrangements in place for overseeing contracts of private labs providing surge testing during this time," said Richard Gleave, UKHSA director and the lead investigator.

"There was no single action that NHS Test and Trace could have taken differently to prevent this error arising in the private laboratory. However, our report sets out clear recommendations to both reduce the risk of incidents like this happening again."

($1 = 0.8349 pounds)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.